NCT07204912 Evaluation of a Neural-Controlled Powered Prosthesis Across Diverse Real-World Tasks
| NCT ID | NCT07204912 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Massachusetts Institute of Technology |
| Condition | Transfemoral Amputation |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2025-05-31 |
| Primary Completion | 2027-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2025-05-31 with a primary completion date of 2027-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the performance and adaptability of a neural-controlled powered knee or ankle prosthesis across diverse real-world mobility tasks. This research aims to assess how compare the sense of embodiment with the device, symmetry, and stability of a person with an lower-extremity amputation walking with a bionic prosthesis and their prescribed prosthesis. Findings from this study will inform future developments in bionic prosthesis design with optimal integration with the human body, with the goal of improving prosthetic integration into daily life.
Eligibility Criteria
Inclusion Criteria: * Male or Female age 18-70. * The patient must have a unilateral transfemoral amputation . * The patient must have the ability to ambulate at variable cadence (an expected lower extremity prosthesis functional level of K3 or above). * The patient must have adequate socket to support the device. Exclusion Criteria: * Women who are pregnant. * Severe co morbidity, atypical skeletal anatomy, or poor general physical/mental health that, in the opinion of the Investigator, will not allow the subject to be a good study candidate (i.e. other disease processes, mental capacity, substance abuse, shortened life expectancy, vulnerable patient population, BMI \>40, etc.).
Contact & Investigator
Hugh Herr
PRINCIPAL INVESTIGATOR
MIT Media Lab
Frequently Asked Questions
Who can join the NCT07204912 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Transfemoral Amputation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07204912 currently recruiting?
Yes, NCT07204912 is actively recruiting participants. Contact the research team at johnmccu@mit.edu for enrollment information.
Where is the NCT07204912 trial being conducted?
This trial is being conducted at Cambridge, United States.
Who is sponsoring the NCT07204912 clinical trial?
NCT07204912 is sponsored by Massachusetts Institute of Technology. The principal investigator is Hugh Herr at MIT Media Lab. The trial plans to enroll 10 participants.